MCM6 and neoplasm: Over a series of gain-of-function and rescue experiments, the results revealed that the methylation-dependent repression of MCM6 due to LINC00472 mediation was the potential mechanism substantiating the anti-tumor and anti-metastatic properties of LINC00472 in TNBC.